Egyptian study checks Real-World value of breast cancer drugs
NCT ID NCT07487129
First seen Mar 31, 2026 · Last updated May 24, 2026 · Updated 9 times
Summary
This study reviewed medical records of 206 people in Egypt with a certain type of advanced breast cancer (HR+/HER2-). Researchers wanted to see how well CDK4/6 inhibitor drugs work in everyday practice, including their benefits, side effects, and cost. The goal was to understand if these expensive drugs are worth using in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gustave Roussy International Hospital in Egypt.
Cairo, Cairo Governorate, Egypt
Conditions
Explore the condition pages connected to this study.